CIK 0001016504 · Non-accelerated filer<br>Smaller reporting company
INTEGRATED BIOPHARMA INC
Sign in to watch- Ticker
- INBP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222407475
- Phone
- 9739260816
- Business address
- 225 LONG AVENUE, BUILDING 15, HILLSIDE, NJ, 07205
- Former names
- INTEGRATED HEALTH TECHNOLOGIES INC, CHEM INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | KAY CHRISTINA Co-Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −55,555 | 144,445 | ||
| 2024-11-25 | Masi Dina Chief Financial Officer | Grant or award | +65,000 | $0.09 | $6K | 212,200 |
| 2024-11-25 | Masi Dina Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −65,000 | 135,000 | ||
| 2024-11-25 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award | +55,555 | $0.09 | $5K | 1,329,022 |
| 2024-11-25 | RIVA SHEPPARD Co-Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −55,555 | 144,445 | ||
| 2024-08-07 | DeSantis Damon Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-08-07 | FRIEDMAN ERIC J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-08-07 | Milmoe William H. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-08-07 | Canarick Robert Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-11-28 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-11-28 | KAY CHRISTINA Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-11-28 | Masi Dina Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-09-20 | Masi Dina Chief Financial Officer | Grant or award | +50,000 | $0.09 | $5K | 147,200 |
| 2023-09-20 | Masi Dina Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −50,000 | $0.09 | $5K | 576,667 |
| 2023-09-20 | KAY CHRISTINA Co-Chief Executive Officer | Grant or award | +50,000 | $0.09 | $5K | 1,273,467 |
| 2023-09-20 | KAY CHRISTINA Co-Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −50,000 | 200,000 | ||
| 2023-09-20 | RIVA SHEPPARD Co-Chief Executive Officer | Grant or award | +50,000 | $0.09 | $5K | 1,273,467 |
| 2023-09-20 | RIVA SHEPPARD Co-Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −50,000 | 200,000 | ||
| 2023-07-18 | Milmoe William H. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-07-18 | Canarick Robert Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 3 of 8 · 160 trades